Skip to main content

Investors

Ulisse Biomed Group is an integrated biotech group with proprietary technologies, developing diagnostic solutions with a focus on public health, distributed diagnostics and molecular innovation.

About Us

We are technology leaders in distribuited and connected diagnostics


Investors

The Ulysses Biomed Group is an integrated biotech group with proprietary technologies, developing diagnostic solutions with a focus on public health, distributed diagnostics and molecular innovation.


Admission document


In order to access this section of the website or download the admission document available in this section, you must read and accept the terms and conditions set out below. By accessing this section of the Website, you agree to be subject to the terms and conditions set out below, which may be amended or updated (and, for that reason, should be read in full each time you access it). The admission document published in this section of the website ("Admission Document") has been prepared in accordance with the AIM Italia issuers' regulations, a multilateral trading system organised and managed by Borsa Italiana S.p.A. (respectively, the "AIM Italia" and the "AIM Issuers' Regulations"), for the purpose of the admission of ordinary shares and warrants denominated "Warrant Ulisse BioMed S.p.A. 2021-2026" (the "Market Warrants") to AIM Italia. The offer of financial instruments contemplated in the Admission Document, the transaction described therein and any other information contained therein do not constitute an "offer to the public", as defined by Legislative Decree No. 58 of 24 February 1998, (the "TUF"), and, therefore, it is not necessary to prepare a prospectus in accordance with the schemes provided for by Commission Delegated Regulation (EU) 2019/980 of 14 March 2019, supplementing Regulation (EU) 2017/1129 of the Parliament and of the Council. The Admission Document therefore does not constitute a prospectus and its publication does not have to be authorised by CONSOB pursuant to Regulation (EU) 2017/1129 or any other rule or regulation governing the preparation and publication of prospectuses pursuant to Articles 94 and 113 of the Consolidated Law on Finance, including the Issuers' Regulation adopted by CONSOB with resolution No. 11971 of 14 May 1999, as subsequently amended and supplemented. The information contained in this section of the website is disseminated in accordance with Articles 17 and 26 of the AIM Issuers' Regulation.

This section of the website, the Admission Document and any other information contained in the following pages are accessible only by persons who: (i) are resident in Italy and are not currently domiciled or otherwise located in the United States of America, Australia, Japan, Canada, as well as in any other country where the dissemination of the Admission Document and/or such information requires the approval of the competent local authorities or is in violation of local rules or regulations ("Other Countries"); and (ii) are not "U.S. Person" as that term is defined in Regulation S of the United States Securities Act of 1933, as amended, nor are they persons acting on their behalf or for their benefit without the existence of a special registration or specific exemption to registration provided for under the United States Securities Act and applicable law. U.S. Persons" in the above sense are precluded from accessing this section of the website, downloading, storing and/or temporarily or permanently saving the Admission Document and any other information contained in this section of the website. The information contained in this section of the website may not be copied or forwarded. For no reason and under no circumstances may the Admission Document and any other information contained in this section of the website be circulated, directly or through third parties, to persons in the conditions set forth in points (i) and (ii) of the preceding paragraph and, in particular, in the United States, Australia, Japan, Canada or Other Countries.

The information contained in this website (or in any other website with which this website has hypertext links) does not constitute an offer, invitation to offer or promotional activity in relation to the Financial Instrument(s) to any citizen or person resident in the United States, Australia, Japan, Canada or the Other Countries. In addition, the Financial Instruments of the Company are not, and will not be, subject to registration under the United States Securities Act of 1993, as amended, or with any regulatory authority of any state or other jurisdiction in the United States and may not be offered or sold in the United States or to, or for the account and benefit of, a "U.S. Person", as defined below, in the absence of such registration or express exemption from such requirements, or in Australia, Japan, Canada or Other Countries. Regulation S of the United States Securities Act of 1933, as amended, defines a "U.S. Person" as: (a) any natural person resident in the United States; (b) "partnerships" and "corporations" formed and organised under the laws of the United States; (c) any property whose directors or managers are a "U.S. Person; (d) trusts, the trustee of which is a U.S. Person; (e) any agency, branch, or subsidiary of a U.S. Person; (f) non-discretionary accounts; (g) other similar accounts (other than property or trusts) held or administered on a fiduciary basis for the account or benefit of a U.S. Person; (h) any other accounts of a U.S. Person; (i) any other property or trusts held or administered on a fiduciary basis for the account or benefit of a U.S. Person; (j) any other property or trusts held or administered on a fiduciary basis for the account or benefit of a U.S. Person.S. Person"; (h) "partnerships" and "corporations" if (i) formed and organized under the laws of any foreign jurisdiction; and (ii) formed by a "U.S. Person" for the principal purpose of investing in securities not registered under the United States Securities Act of 1933, as amended, unless formed or organized and owned by accredited investors (as defined in Rule 501(a) of the United States Securities Act of 1933) who are not natural persons, estates or trusts.

In order to access this section of the website, the Admission Document and any other information contained in the following pages, I declare under my full responsibility that I am a resident of Italy and that I am not currently domiciled or located in the United States of America, Australia, Japan, Canada or the Other Countries and that I am not a "U.S. Person" as defined in Regulation S of the United States Securities Act of 1933, as amended.

* * * * *

The Offer is addressed to "qualified investors" as defined in Article 100 of the TUF and the combined provisions of Articles 34-ter of the Regulation on Issuers and 35(1)(d) of the Regulation on Intermediaries, as well as to other persons in the European Economic Area (EEA), excluding Italy, who are "qualified investors" within the meaning of Article 2, lett. e of Regulation (EU) 2017/1129, with the exclusion of institutional investors from Australia, Canada, Japan and the United States and any other foreign country in which the offer is not possible in the absence of an authorisation from the competent authorities, as well as to the general public in Italy in a manner such, by quantity of the offer, as to fall within the cases of exemption set forth in Article 3 of Regulation (EU) 2017/1129, Article 100 of the TUF and Article 34-ter, paragraph 01, of the Issuers' Regulations, with the consequent exclusion from the publication of a prospectus.

* * * * *

This press release does not constitute an offer to the public of financial products in Italy within the meaning of Article 1(1)(t) of Legislative Decree No. 58 of 24 February 1998. This press release (including the information contained herein) does not constitute or form part of an offer to the public of financial products or a solicitation of offers to purchase financial products and an offer to sell such products will not be made in any jurisdiction in which such offer or sale would be contrary to applicable law. This release does not constitute an offer to sell financial products in the United States of America, Australia, Canada and Japan and any other jurisdiction where such offer or sale is prohibited and may not be published or distributed, directly or indirectly, in such jurisdictions. The financial products referred to in this release have not been and will not be registered under the United States Securities Act of 1933, as amended and such products may not be offered or sold in the United States of America absent registration or an exemption from the registration requirements. The documentation relating to the Offer has not been/will not be submitted to CONSOB and Borsa Italiana S.p.A. for approval.


Investor Relations Manager

Contact

Gabriele Salaris

  • Email
    This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Email
    This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Phone